Transforming growth factor β: A potential biomarker and therapeutic target of ventricular remodeling

被引:44
作者
Ma, Yuan [1 ,5 ]
Zou, Hai [1 ,5 ]
Zhu, Xing-Xing [2 ,5 ]
Pang, Jie [1 ,5 ]
Xu, Qiang [1 ,5 ]
Jin, Qin-Yang [1 ,5 ]
Ding, Ya-Hui [1 ,5 ]
Zhou, Bing [3 ,5 ]
Huang, Dong-Sheng [4 ,5 ]
机构
[1] Zhejiang Prov Peoples Hosp, Dept Cardiol, Hangzhou, Zhejiang, Peoples R China
[2] Zhejiang Prov Peoples Hosp, Dept Nephrol, Hangzhou, Zhejiang, Peoples R China
[3] Zhejiang Prov Peoples Hosp, Dept Cardiac Surg, Hangzhou, Zhejiang, Peoples R China
[4] Zhejiang Prov Peoples Hosp, Dept Hepatobiliary Surg, Hangzhou, Zhejiang, Peoples R China
[5] Hangzhou Med Coll, Peoples Hosp, Hangzhou, Zhejiang, Peoples R China
关键词
transforming growth factor beta; myocardial fibrosis; ventricular remodeling; mechanism; targets; SPONTANEOUSLY HYPERTENSIVE-RATS; BETA/SMAD SIGNALING PATHWAY; REGULATES CARDIAC FIBROSIS; MYOCARDIAL-INFARCTION; PRESSURE-OVERLOAD; HEART-FAILURE; ENDOGLIN EXPRESSION; WNT/BETA-CATENIN; AORTIC-STENOSIS; SMAD PROTEINS;
D O I
10.18632/oncotarget.17255
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Transforming growth factor beta (TGF- beta) is a multifunctional cytokine that is synthesized by many types of cells and regulates the cell cycle. Increasing evidence has led to TGF-beta receiving increased and deserved attention in recent years because it may play a potentially novel and critical role in the development and progression of myocardial fibrosis and the subsequent progress of ventricular remodeling (VR). Numerous studies have highlighted a crucial role of TGF-beta in VR and suggest potential therapeutic targets of the TGF-beta signaling pathways for VR. Changes in TGF-beta activity may elicit anti-VR activity and may serve as a novel therapeutic target for VR therapy. This review we discusses the smad-dependent signaling pathway, such as TGF-beta/Smads, TGF-beta/Sirtuins, TGF-beta/BMP, TGF-beta/miRNAs, TGF-beta/MAPK, and Smad-independent signaling pathway of TGF-beta, such as TGF-beta/PI3K/Akt, TGF-beta/Rho/ROCK, TGF-beta/Wnt/beta-catenin in the cardiac fibrosis and subsequent progression of VR. Furthermore, agonists and antagonists of TGF-beta as potential therapeutic targets in VR are also described.
引用
收藏
页码:53780 / 53790
页数:11
相关论文
共 86 条
[1]   Activation of canonical Wnt signalling is required for TGF-β-mediated fibrosis [J].
Akhmetshina, Alfiya ;
Palumbo, Katrin ;
Dees, Clara ;
Bergmann, Christina ;
Venalis, Paulius ;
Zerr, Pawel ;
Horn, Angelika ;
Kireva, Trayana ;
Beyer, Christian ;
Zwerina, Jochen ;
Schneider, Holm ;
Sadowski, Anika ;
Riener, Marc-Oliver ;
MacDougald, Ormond A. ;
Distler, Oliver ;
Schett, Georg ;
Distler, Joerg H. W. .
NATURE COMMUNICATIONS, 2012, 3
[2]  
[Anonymous], PHYSL REP
[3]   Sirt7 Contributes to Myocardial Tissue Repair by Maintaining Transforming Growth Factor-β Signaling Pathway [J].
Araki, Satoshi ;
Izumiya, Yasuhiro ;
Rokutanda, Taku ;
Ianni, Alessandro ;
Hanatani, Shinsuke ;
Kimura, Yuichi ;
Onoue, Yoshiro ;
Senokuchi, Takafumi ;
Yoshizawa, Tatsuya ;
Yasuda, Osamu ;
Koitabashi, Norimichi ;
Kurabayashi, Masahiko ;
Braun, Thomas ;
Bober, Eva ;
Yamagata, Kazuya ;
Ogawa, Hisao .
CIRCULATION, 2015, 132 (12) :1081-1093
[4]   Cardioprotective role of growth/differentiation factor 1 in post-infarction left ventricular remodelling and dysfunction [J].
Bao, Ming-Wei ;
Zhang, Xiao-Jing ;
Li, Liangpeng ;
Cai, Zhongxiang ;
Liu, Xiaoxiong ;
Wan, Nian ;
Hu, Gangying ;
Wan, Fengwei ;
Zhang, Rui ;
Zhu, Xueyong ;
Xia, Hao ;
Li, Hongliang .
JOURNAL OF PATHOLOGY, 2015, 236 (03) :360-372
[5]   microRNA-122 down-regulation may play a role in severe myocardial fibrosis in human aortic stenosis through TGF-β1 up-regulation [J].
Beaumont, Javier ;
Lopez, Begona ;
Hermida, Nerea ;
Schroen, Blanche ;
Jose, Gorka San ;
Heymans, Stephane ;
Valencia, Felix ;
Jose Gomez-Doblas, Juan ;
De Teresa, Eduardo ;
Diez, Javier ;
Gonzalez, Arantxa .
CLINICAL SCIENCE, 2014, 126 (7-8) :497-506
[6]   A novel VNTR enhancer within the SIRT3 gene, a human homologue of SIR2, is associated with survival at oldest ages [J].
Bellizzi, D ;
Rose, G ;
Cavalcante, P ;
Covello, G ;
Dato, S ;
De Rango, F ;
Greco, V ;
Maggiolini, M ;
Feraco, E ;
Mari, V ;
Franceschi, C ;
Passarino, G ;
De Benedictis, G .
GENOMICS, 2005, 85 (02) :258-263
[7]   Inhibition of SMAD2 phosphorylation preserves cardiac function during pressure overload [J].
Bjornstad, Johannes L. ;
Skrbic, Biljana ;
Marstein, Henriette S. ;
Hasic, Almira ;
Sjaastad, Ivar ;
Louch, William E. ;
Florholmen, Geir ;
Christensen, Geir ;
Tonnessen, Theis .
CARDIOVASCULAR RESEARCH, 2012, 93 (01) :100-110
[8]   Islet-1 is a dual regulator of fibrogenic epithelial-to-mesenchymal transition in epicardial mesothelial cells [J].
Bronnum, Hasse ;
Andersen, Ditte C. ;
Schneider, Mikael ;
Nossent, Anne Yael ;
Nielsen, Solveig B. ;
Sheikh, Soren P. .
EXPERIMENTAL CELL RESEARCH, 2013, 319 (04) :424-435
[9]   High glucose induces Smad activation via the transcriptional coregulator p300 and contributes to cardiac fibrosis and hypertrophy [J].
Bugyei-Twum, Antoinette ;
Advani, Andrew ;
Advani, Suzanne L. ;
Zhang, Yuan ;
Thai, Kerri ;
Kelly, Darren J. ;
Connelly, Kim A. .
CARDIOVASCULAR DIABETOLOGY, 2014, 13
[10]   Inhibition of TGF-β1 signaling by eNOS gene transfer improves ventricular remodeling after myocardial infarction through angiogenesis and reduction of apoptosis [J].
Chen, Lei-Lei ;
Yin, Hang ;
Huang, Jun .
CARDIOVASCULAR PATHOLOGY, 2007, 16 (04) :221-230